[1]
R. . Govindarajan, S. Iyadurai, A. Karenevich, L. Herbelin, J. Statland, and R. Barohn, “EE2: 3,4-Diaminopyridine Phosphate for AAL- The EEDAPP-ALS Trial”, rrnmf, vol. 3, no. 1, pp. 34–62, Mar. 2022, doi: 10.17161/rrnmf.v3i1.16747.